Lack of association between the COMT rs4680 polymorphism and ovarian cancer risk: Evidence from a meta-analysis of 3,940 individuals

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 18, 2014, Pages 7941-7945

  Du, Jin Ze ^a   Dong, Yu Ling ^a   Wan, Guo Xing ^a,b   Tao, Lin ^a   Lu, Li Xia ^a   Li, Feng ^a   Pang, Li Juan ^a   Jia, Wei ^a  

^a SHIHEZI UNIVERSITY   (China)

^b HUBEI UNIVERSITY OF MEDICINE   (China)

Author keywords

COMT; Genetic; Meta analysis; Ovarian cancer; Polymorphism

Indexed keywords

CATECHOL METHYLTRANSFERASE; COMT PROTEIN, HUMAN;

CASE CONTROL STUDY; FEMALE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HUMAN; META ANALYSIS; OVARY TUMOR; PROGNOSIS; RISK FACTOR;

CASE-CONTROL STUDIES; CATECHOL O-METHYLTRANSFERASE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; OVARIAN NEOPLASMS; POLYMORPHISM, GENETIC; PROGNOSIS; RISK FACTORS;

EID: 84908022545     PISSN: 15137368     EISSN: None     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.18.7941     Document Type: Article

References (31)

1. Begg CB, Mazumdar M (1994). Operating characteristics of a rank correlation test for publication bias. Biometrics, 1088-101.
2. Chan KK-L, Leung TH-Y, Chan DW, et al (2014). Targeting estrogen receptor subtypes (ERa and ERβ) with selective ER modulators in ovarian cancer. J Endocrinol, 221, 325-36.
3. Cochran WG (1950). The comparison of percentages in matched samples. Biometrika, 256-66.
4. Dawling S, Roodi N, Mernaugh RL, et al (2001). Catechol-O-methyltransferase (COMT)-mediated metabolism of catechol estrogens comparison of wild-type and variant COMT isoforms. Cancer Res, 61, 6716-22.
5. Delort L, Chalabi N, Satih S, et al (2008). Association between genetic polymorphisms and ovarian cancer risk. Anticancer Res, 28, 3079-81.
6. DerSimonian R, Laird N (1986). Meta-analysis in clinical trials. Control Clin Trials, 7, 177-88.
7. Egger M, Smith GD, Schneider M, et al (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-34.
8. Emori MM, Drapkin R (2014). The hormonal composition of follicular fluid and its implications for ovarian cancer pathogenesis. Reprod Biol Endocrinol, 12, 60.
9. Garner EI, Stokes EE, Berkowitz RS, et al (2002). Polymorphisms of the estrogen-metabolizing genes CYP17 and catechol-O-methyltransferase and risk of epithelial ovarian cancer. Cancer Res, 62, 3058-62.
10. Goodman JE, Lavigne JA, Hengstler JG, et al (2000). Catechol-O-methyltransferase polymorphism is not associated with ovarian cancer risk. Cancer Epidemiol Biomarkers Prev, 9, 1373-6.
11. Goodman MT, McDuffie K, Kolonel LN, et al (2001). Case-control study of ovarian cancer and polymorphisms in genes involved in catecholestrogen formation and metabolism. Cancer Epidemiol Biomarkers Prev, 10, 209-16.
12. Grossman M, Emanuel B, Budarf M (1992). Chromosomal mapping of the human catechol-O-methyltransferase gene to 22q11. 1g q11. 2. Genomics, 12, 822-5.
13. Guldberg HC, Marsden CA (1975). Catechol-O-methyl transferase: pharmacological aspects and physiological role. Pharmacol Rev, 27, 135-206.
14. He X-F, Wei W, Li S-X, et al (2012). Association between the COMT Val158Met polymorphism and breast cancer risk: a meta-analysis of 30,199 cases and 38,922 controls. Mol Biol Rep, 39, 6811-23.
15. Higgins J, Thompson SG (2002). Quantifying heterogeneity in a meta-analysis. Stat Med, 21, 1539-58.
16. Higgins J, Thompson SG, Deeks JJ, et al (2003). Measuring inconsistency in meta-analyses. Bmj, 327, 557-60.
17. Hirata H, Hinoda Y, Okayama N, et al (2008). COMT polymorphisms affecting protein expression are risk factors for endometrial cancer. Mol carcinog, 47, 768-74.
18. Holt SK, Rossing MA, Malone KE, et al (2007). Ovarian cancer risk and polymorphisms involved in estrogen catabolism. Cancer Epidemiol Biomarkers Prev, 16, 481-9.
19. Jakubowska A, Gronwald J, Menkiszak J, et al (2010). BRCA1-associated breast and ovarian cancer risks in Poland: no association with commonly studied polymorphisms. Breast Cancer Res Treat, 119, 201-11.
20. Lachman HM, Papolos DF, Saito T, et al (1996). Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenet Genomics, 6, 243-50.
21. Lin G, Zhao J, Wu J, et al (2012). Contribution of catechol-O-methyltransferase Val158Met polymorphism to endometrial cancer risk in postmenopausal women: a meta-analysis. Genet Mol Res, 12, 6442-53.
22. Liu X-H, Man Y-N, Wu X-Z (2014). Recurrence season impacts the survival of epithelial ovarian cancer patients. Asian Pac J Cancer Prev, 15, 1627-32.
23. Mannisto P, Ulmanen I, Lundstrom K, et al (1992). Characteristics of catechol O-methyltransferase (COMT) and properties of selective COMT inhibitors. Prog Drug Res, 39, 291-350
24. Mantel N, Haenszel W (1959). Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst, 22, 719-48.
25. Mao C, Wang X-W, Qiu L-X, et al (2010). Lack of association between catechol-O-methyltransferase Val108/158Met polymorphism and breast cancer risk: a meta-analysis of 25,627 cases and 34,222 controls. Breast Cancer Res Treat, 121, 719-25.
26. Schüler S, Lattrich C, Skrzypczak M, et al (2014a). Icb-1 gene polymorphism rs1467465 is associated with susceptibility to ovarian cancer. J Ovarian Res, 7, 42.
27. Schüler S, Lattrich C, Skrzypczak M, et al (2014b). Polymorphisms in the promoter region of ESR2 gene and susceptibility to ovarian cancer. Gene, 546, 283-7.
28. Sellers TA, Schildkraut JM, Pankratz VS, et al (2005). Estrogen bioactivation, genetic polymorphisms, and ovarian cancer. Cancer Epidemiol Biomarkers Prev, 14, 2536-43.
29. Tian C, Liu L, Yang X, et al (2014). The Val 158 Met polymorphism in the COMT gene is associated with increased cancer risks in Chinese population. Tumor Biol, 35, 3003-8.
30. Wan G-X, Cao Y-W, Li W-Q, et al (2014). The Catechol-O-Methyltransferase Val158Met Polymorphism Contributes to the Risk of Breast Cancer in the Chinese Population: An Updated Meta-Analysis. J Breast Cancer, 17, 149-56.
31. Weinshilboum RM, Raymond FA (1977). Inheritance of low erythrocyte catechol-o-methyltransferase activity in man. Am J Hum Genet, 29, 125.